296 related articles for article (PubMed ID: 26916353)
1. Skin cancer in kidney transplant recipients affected with autosomal dominant polycystic kidney disease.
Jankowska M; Dębska-Ślizień A; Imko-Walczuk B; Piesiaków ML; Lizakowski S; Czarnacka K; Rutkowski B
Clin Transplant; 2016 Apr; 30(4):339-43. PubMed ID: 26916353
[No Abstract] [Full Text] [Related]
2. Autosomal dominant polycystic kidney disease: risk factor for nonmelanoma skin cancer following kidney transplantation.
Bretagnol A; Halimi JM; Roland M; Barbet C; Machet L; Al Najjar A; Marlière JF; Badin J; Nivet H; Lebranchu Y; Büchler M
Transpl Int; 2010 Sep; 23(9):878-86. PubMed ID: 20230542
[TBL] [Abstract][Full Text] [Related]
3. Belatacept reduces skin cancer risk in kidney transplant recipients.
Wang M; Mittal A; Colegio OR
J Am Acad Dermatol; 2020 Apr; 82(4):996-998. PubMed ID: 31589945
[No Abstract] [Full Text] [Related]
4. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant Outcomes of Patients With Autosomal Dominant Polycystic Kidney Disease Versus Other Recipients: A 10-Year Report From South of Iran.
Roozbeh J; Malekmakan L; Harifi MM; Tadayon T
Exp Clin Transplant; 2018 Dec; 16(6):676-681. PubMed ID: 27759554
[TBL] [Abstract][Full Text] [Related]
6. Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort.
Stapleton CP; Birdwell KA; McKnight AJ; Maxwell AP; Mark PB; Sanders ML; Chapman FA; van Setten J; Phelan PJ; Kennedy C; Jardine A; Traynor JP; Keating B; Conlon PJ; Cavalleri GL
Am J Transplant; 2019 Mar; 19(3):801-810. PubMed ID: 30085400
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with skin cancer in lung transplant recipients: A single-center experience.
Elnahas S; Olson MT; Kang P; Panchanathan R; Masuda T; Walia R; Zeitouni NC; Smith MA; Bremner RM
Clin Transplant; 2019 Dec; 33(12):e13718. PubMed ID: 31545540
[TBL] [Abstract][Full Text] [Related]
8. Acute graft pyelonephritis in renal transplant recipients: incidence, risk factors and long-term outcome.
Fiorante S; Fernández-Ruiz M; López-Medrano F; Lizasoain M; Lalueza A; Morales JM; San-Juan R; Andrés A; Otero JR; Aguado JM
Nephrol Dial Transplant; 2011 Mar; 26(3):1065-73. PubMed ID: 20805254
[TBL] [Abstract][Full Text] [Related]
9. Outcome of Kidney Transplant in Patients with Polycystic Kidney Disease: A Single-Center Study in Tunisia.
Barbouch S; Hajji M; Hedri H; El Younsi F; Ben Hamida F; Bacha MM; Ounissi M; Abderrahim E; Ben Abdallah T
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):196-199. PubMed ID: 28260467
[TBL] [Abstract][Full Text] [Related]
10. Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.
Pinho A; Gouveia M; Cardoso JC; Xavier MM; Vieira R; Alves R
An Bras Dermatol; 2016; 91(4):455-62. PubMed ID: 27579740
[TBL] [Abstract][Full Text] [Related]
11. Skin cancer following kidney transplantation: a single-center experience.
Karczewski M; Stronka M; Karczewski J; Wiktorowicz K
Transplant Proc; 2011 Dec; 43(10):3760-1. PubMed ID: 22172842
[TBL] [Abstract][Full Text] [Related]
12. Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection.
Alhamad T; Venkatachalam K; Linette GP; Brennan DC
Am J Transplant; 2016 Apr; 16(4):1332-3. PubMed ID: 26752406
[No Abstract] [Full Text] [Related]
13. Clinical relevance of preformed IgG and IgM antibodies against donor endothelial progenitor cells in recipients of living donor kidney grafts.
Daniel V; Sadeghi M; Suesal C; Scherer S; Tran H; Gombos P; Trojan K; Morath C; Opelz G
Clin Transplant; 2016 Feb; 30(2):124-30. PubMed ID: 26537026
[TBL] [Abstract][Full Text] [Related]
14. [Risk factors of non melanoma skin cancers in kidney transplant patients].
Sułowicz J; Wojas-Pelc A; Ignacak E; Betkowska-Prokop A; Kuzniewski M; Sułowicz W
Przegl Lek; 2014; 71(1):19-25. PubMed ID: 24712264
[TBL] [Abstract][Full Text] [Related]
15. Post kidney transplantation Kaposi's sarcoma: the experience of a Mediterranean North African center.
Gorsane I; Bacha MM; Abderrahim E; Amri N; Hajri M; Ounissi M; Harzallah A; El Younsi F; Hedri H; Ben Abdallah T
Clin Transplant; 2016 Apr; 30(4):372-9. PubMed ID: 26782303
[TBL] [Abstract][Full Text] [Related]
16. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
Jensen AO; Svaerke C; Farkas D; Pedersen L; Kragballe K; Sørensen HT
Acta Derm Venereol; 2010 Sep; 90(5):474-9. PubMed ID: 20814621
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial.
Favi E; Spagnoletti G; Salerno MP; Pedroso JA; Romagnoli J; Citterio F
Clin Transplant; 2013; 27(4):E359-67. PubMed ID: 23710603
[TBL] [Abstract][Full Text] [Related]
18. Depressive symptoms, frailty, and adverse outcomes among kidney transplant recipients.
Konel JM; Warsame F; Ying H; Haugen CE; Mountford A; Chu NM; Crews DC; Desai NM; Garonzik-Wang JM; Walston JD; Norman SP; Segev DL; McAdams-DeMarco MA
Clin Transplant; 2018 Oct; 32(10):e13391. PubMed ID: 30152107
[TBL] [Abstract][Full Text] [Related]
19. Neoplastic skin lesions in Iranian renal transplant recipients: the role of immunosuppressive therapy.
Zamanian A; Farshchian M
J Drugs Dermatol; 2007 Jul; 6(7):703-6. PubMed ID: 17763593
[TBL] [Abstract][Full Text] [Related]
20. Incidence, etiology, and significance of acute kidney injury in the early post-kidney transplant period.
Panek R; Tennankore KK; Kiberd BA
Clin Transplant; 2016 Jan; 30(1):66-70. PubMed ID: 26497636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
